MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

NCT02880241 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Due to a Medicines for Malaria Venture (MMV) strategic business decision

Conditions

Malaria

Interventions

DRUG: MMV390048

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]